|
1
|
Gao KT and Lian D: Long non-coding RNA
MALAT1 is an independent prognostic factor of osteosarcoma. Eur Rev
Med Pharmacol Sci. 20:3561–3565. 2016.PubMed/NCBI
|
|
2
|
Sun XZ, Liao Y and Zhou CM: NKD2 a novel
marker to study the progression of osteosarcoma development. Eur
Rev Med Pharmacol Sci. 20:2799–2804. 2016.PubMed/NCBI
|
|
3
|
Yan M, Ni J, Song D, Ding M and Huang J:
Activation of unfolded protein response protects osteosarcoma cells
from cisplatin-induced apoptosis through NF-κB pathway. Int J Clin
Exp Pathol. 8:10204–10215. 2015.PubMed/NCBI
|
|
4
|
Xia M, Tong JH, Ji NN, Duan ML, Tan YH and
Xu JG: Tramadol regulates proliferation, migration and invasion via
PTEN/PI3K/AKT signaling in lung adenocarcinoma cells. Eur Rev Med
Pharmacol Sci. 20:2573–2580. 2016.PubMed/NCBI
|
|
5
|
Ersahin A, Acet M, Acet T and Yavuz Y:
Disturbed endometrial NF-κB expression in women with recurrent
implantation failure. Eur Rev Med Pharmacol Sci. 20:5037–5040.
2016.PubMed/NCBI
|
|
6
|
Wang L, Yang L, Lu Y, Chen Y, Liu T, Peng
Y, Zhou Y, Cao Y, Bi Z, Liu T, et al: Osthole induces cell cycle
arrest and inhibits migration and invasion via PTEN/Akt pathways in
osteosarcoma. Cell Physiol Biochem. 38:2173–2182. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ma T, Guo CJ, Zhao X, Wu L, Sun SX and Jin
QH: The effect of curcumin on NF-κB expression in rat with lumbar
intervertebral disc degeneration. Eur Rev Med Pharmacol Sci.
19:1305–1314. 2015.PubMed/NCBI
|
|
8
|
Shen L, Chen XD and Zhang YH: MicroRNA-128
promotes proliferation in osteosarcoma cells by downregulating
PTEN. Tumour Biol. 35:2069–2074. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pang PC, Shi XY, Huang WL and Sun K:
miR-497 as a potential serum biomarker for the diagnosis and
prognosis of osteosarcoma. Eur Rev Med Pharmacol Sci. 20:3765–3769.
2016.PubMed/NCBI
|
|
10
|
Ju L, Zhou YM and Yang GS: Up-regulation
of long non-coding RNA BCAR4 predicts a poor prognosis in patients
with osteosarcoma, and promotes cell invasion and metastasis. Eur
Rev Med Pharmacol Sci. 20:4445–4451. 2016.PubMed/NCBI
|
|
11
|
Sun H, Zheng X, Wang Q, Yan J, Li D, Zhou
Y, Lin Y, Zhang L and Wang X: Concurrent blockade of NF-κB and Akt
pathways potentiates cisplatin's antitumor activity in vivo.
Anticancer Drugs. 23:1039–1046. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mongre RK, Sodhi SS, Ghosh M, Kim JH, Kim
N, Sharma N and Jeong DK: A new paradigm to mitigate osteosarcoma
by regulation of microRNAs and suppression of the NF-κB signaling
cascade. Dev Reprod. 18:197–212. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu CJ, Yu KL, Liu GL and Tian DH: MiR 214
promotes osteosarcoma tumor growth and metastasis by decreasing the
expression of PTEN. Mol Med Rep. 12:6261–6266. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kawano M, Tanaka K, Itonaga I, Ikeda S,
Iwasaki T and Tsumura H: microRNA-93 promotes cell proliferation
via targeting of PTEN in osteosarcoma cells. J Exp Clin Cancer Res.
34:762015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shang ZM, Tang JD, Jiang QQ, Guo A, Zhang
N, Gao ZX and Ji WS: Role of Δ133p53 in tumor necrosis
factor-induced survival of p53 functions in MKN45 gastric cancer
cell line. Eur Rev Med Pharmacol Sci. 19:2416–2422. 2015.PubMed/NCBI
|
|
16
|
Tian Z, Guo B, Yu M, Wang C, Zhang H,
Liang Q, Jiang K and Cao L: Upregulation of micro-ribonucleic
acid-128 cooperating with downregulation of PTEN confers metastatic
potential and unfavorable prognosis in patients with primary
osteosarcoma. Onco Targets Ther. 7:1601–1608. 2014.PubMed/NCBI
|
|
17
|
Hu Y, Xu S, Jin W, Yi Q and Wei W: Effect
of the PTEN gene on adhesion, invasion and metastasis of
osteosarcoma cells. Oncol Rep. 32:1741–1747. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Song D, Ni J, Xie H, Ding M and Wang J:
DNA demethylation in the PTEN gene promoter induced by
5-azacytidine activates PTEN expression in the MG-63 human
osteosarcoma cell line. Exp Ther Med. 7:1071–1076. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Loftus JP, Cavatorta D, Bushey JJ, Levine
CB, Sevier CS and Wakshlag JJ: The 5-lipoxygenase inhibitor
tepoxalin induces oxidative damage and altered PTEN status prior to
apoptosis in canine osteosarcoma cell lines. Vet Comp Oncol.
14:e17–e30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu Y, Li F, Xu T and Sun J: Tetrandrine
prevents multidrug resistance in the osteosarcoma cell line, U-2OS,
by preventing Pgp overexpression through the inhibition of NF-κB
signaling. Int J Mol Med. 39:993–1000. 2017. View Article : Google Scholar : PubMed/NCBI
|
